Abstract: Mutation testing, a mainstream fault-based software testing technique, can mimic a wide variety of software faults by seeding them into the target program and resulting in the so-called ...

Learn how to build and test narrowboat steps with this companionway tutorial, covering precise measurements, secure installation, and safety checks. Perfect for DIY narrowboat owners aiming to improve ...

Angelina Jolie declared that her double mastectomy scars “are a choice” she is “grateful” she was able to make. “I’ve always been someone more interested in the scars and the life that people carry,” ...

More children are testing positive for the flu as Californians continue to cough, hack and wheeze their way through an explosive influenza season. Influenza's rate of spread "is elevated in California ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...

—Dr. McArthur of University of Texas Southwestern Medical School discusses the ideal time to pursue genomic testing and how it may be able to help guide treatment. (1:45) The Current and Future Roles ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

The SERENA-6 trial focused on ESR1 mutation detection in metastatic HR-positive, HER2-negative breast cancer to extend first-line treatment efficacy. Serial liquid biopsies were used to identify ESR1 ...